Histology and Cytology Market

Histology and Cytology Market Size by Type (Histology, Cytology), Test Type (Microscopy Tests, Molecular Genetics Tests, Flow Cytometry), Application, End-User, Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2021 to 2028

Base Year: 2020 Historical Data: 2018-19
  • Report ID: TBI-12506
  • Published Date: Oct, 2021
  • Pages: 215
  • Category: Healthcare
  • Format: PDF
Buy @ $4699.00 Request Sample PDF

Global histology and cytology market is projected to reach USD 33.69 billion by 2028, at a CAGR of 14.97% from 2021 to 2028. Global histology and cytology market is witnessing a considerable growth owing to increasing incidences of cervical and breast cancer among women across the globe.

Market Overview:

Histology and cytology is the study to describe the structure of the tissues and cells of plants and animals, especially at the microscopic level. Cytology involves the research of cells, and histology consists of the study of tissue, both of which are derived from various organs of the human body. Cytology is the minuscule inspection of tissue and cells, which is collected from the human or animal body. It is commonly used to diagnose growths of tumors and also used to study abnormal body fluid, and organs such as liver, kidney, lung, and lymph. Most commonly, fine needle biopsy or fine-needle aspiration is performed to collect cells. Other techniques such as skin scraping, impression smear, cotton-tipped swabs are used for the collection of samples. These techniques are used for preliminary inspection for diagnosis. Cytology does not indicate the growth rate of a tumour or whether the tumour may be invading surrounding tissues, but it often helps physicians to determine what further steps are needed. Histology is the study of the cells, tissues and organs at the microscopic level. It also helps us understand the relationship between function and structure of the tissues and organs.

Histology and cytology market has been witnessing the massive growth in the healthcare industry as a number of diseases can be diagnosed through these clinical studies. With the aid of histology and cytology, a number of infectious diseases can be identified such as cervical disease, cancer, abnormal growth, hepatitis, inflammatory diseases, diarrhoea, leukaemia, smallpox, rabies etc. From the commercial perspective, cytology and histology are used in the diagnostic and research procedure. The market trends are determined along with manufacturer’s preference for the development of reagents and kits for these clinical procedures.

Get an overview of this study by requesting a free sample

Market Dynamics:

Drivers:
  • Increasing prevalence of cancer across the globe

As per the study by WHO, cancer is the second largest cause of death in the world and is responsible for an estimated 9.6 million deaths in 2018. Furthermore, globally, about 1 in 6 deaths happened due to cancer. In addition to this, cervical cancer has a high incidence worldwide, being the third most frequent type of cancer in the females and the second leading cause of cancer-related mortality in women. Cervical cancer is caused by infection of human papillomavirus (HP) among the women. Thus, increasing prevalence of cancer is anticipated to drive the market growth over the forecast period. Screening of cervical cancerous cells is mainly done by using liquid-based cytology test and pap smear test, which helps to reduce the morbidity and mortality.

  • Technological advancement in the diagnostics techniques 

The rapid technological advances are occurring in the field of cytology and histology, particularly in the field of digital imaging. The accessibility provided by digital imaging in histology and cytology helps to improve the quality and efficiency of the services, primarily by getting the expert to remotely look at the sample slide. This improved accessibility eliminates the need to ship slides and saves time for glass slides or transport pathologists. Thus, technological advancement is likely to drive the histology and pathology market

Restraints:
  • Risk of contamination could hamper the market growth

Laboratory contamination is one of the critical challenges, which is expected to hamper the market growth. Cytology and histology specimen contamination leads to a false‐positive surgical pathology diagnosis. In particular, mould and fungal-based contaminants could be a devastating problem for the laboratory.

Opportunities:
  • Growth opportunities in the emerging economies

Breast cancer and cervical cancer among females has been a rapid rise in several emerging economies such as India, China, and Southeast Asian countries. These countries are witnessing more and more numbers of patients being diagnosed with breast cancer and cervical cancer in the younger age groups (in their thirties and forties). In addition to this, cervical cancer is one of the most common cancers among women in many developing countries. It is estimated that around 83% per cent of all the new cases of cervical cancer occur in developing countries. Thus, there are several potential growth opportunities for vendors in the developing countries.

Challenges:
  • Lack of awareness in the emerging countries

Lack of knowledge, unwillingness for the test and non-availability of resources for undertaking Pap smear has taken a severe problem in the prevention of cervical cancer which is the common gynaecological cancer in the emerging countries. In addition to this, people are unaware of the diagnostics tests, which is hampering the growth of the market.

Segmentation Analysis:

The global histology and cytology market classified based on type, test type, application, end-user, and regions.

  • The type segment is divided into histology and cytology. Cytology segment further classified into cervical cancer, breast cancer, and other cancers. The cytology segment held the largest market share and valued at USD 7.30 billion in 2020, owing to the rising prevalence of different type of cancers across the globe. It is widely used for the cell screening test, owing to its low cost, high specificity, and adequate sensitivity. Cytology serves as one of the essential tools in screening and diagnosing cancer. It helps to detect the cancer tumour at an early stage, which improves the chances of recovery.
  • The test type segment includes microscopy tests, molecular genetics tests, and flow cytometry. Flow cytometry segment is anticipated to grow at the highest CAGR of 15.01% over the forecast period. It provides a well-established and cost-effective method to identify cells in solution and commonly used for evaluating bone marrow, peripheral blood, and other body fluids. This test type has become increasingly available in clinical laboratories and hospitals, and its application are rising with significant improvements in instrumentation and the availability of an array of monoclonal reagents.
  • The application segment is divided into clinical diagnostics, molecular diagnostics study, cell signaling, and others. The clinical diagnostics is anticipated to grow at the highest CAGR of 15.1% over the forecast period, due to increasing usage of histology and cytology for diagnoses of cancer and certain infections. Rise in awareness among physicians of its diagnostic possibilities and advantages over others, further driving the growth of the market. In addition to this, histology and cytology market had also experienced tremendous growth, owing to the rising number of diseases diagnosed through clinical research has increased.
  • The end-user segment is divided into hospitals/clinics, biopharmaceutical companies, academia, and others. Hospitals/clinics accounted for a major market share and valued at USD 5.08 billion in the year 2020. This is mainly due to higher purchasing power, well-equipped operating & diagnostic rooms, presence of highly skilled healthcare professionals, easy accessibility, and better health coverage for hospital-based healthcare services from various private and group insurance plans.
Regional Segmentation Analysis:

The regions analysed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. The North America region dominated the global histology and cytology market and valued at USD 5.24 billion in 2020.

  • This is because North America is growing tremendously in terms of the healthcare industry. North America region has become the hub for the technological development and transformation of the industry. Availability of well-equipped diagnostic clinics, better coverage for diagnosis and treatment, and increased prevalence of cancer in the region, positively influencing the growth of the market. In addition to this, the presence of key vendors in the region, further driving the growth of the market in the North America region.
  • The Asia Pacific region is anticipated to grow at the highest CAGR during the forecast period. This is mainly due to rising awareness related to cancer and increasing healthcare expenditure across the region is positively influencing market growth in the region. Furthermore, China, Japan, South Korea, and India are some of the key companies in terms of growth prospects of the market.

North America Histology and Cytology Market Share in 2020- 42.6%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Competitive Analysis:

The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances and partnerships to improve their market position in the global histology and cytology industry.

In March 2018, Becton Dickinson Company announced the launch of BD SurePath Direct to Slide, liquid-based cytology (LBC) test used for screening and detection of pre-cancerous lesions, cervical cancer, abnormal cells and all other cytologic categories.

In April 2019, Hologic, Inc. announced that the ThinPrep Genesis processor for cytology slide and molecular test preparation had received a CE IVD mark in Europe. The system features increased automation capabilities, together with ergonomic and chain of custody benefits, compared to older instruments.

List of Key Market Players:

  • Abbott Laboratories
  • Becton Dickinson and Company
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Trivitron Healthcare.
  • Southwest Precision Instruments
  • Merck KGaA
  • Allergan, Plc
  • Promega Corporation
  • Agilent Technologies Inc.

Key Target Audience

  • Healthcare Institute
  • Drug Manufacture
  • Pharmaceutical Companies
  • Government Authorities and R&D Institutions
  • World Health Organization
  • Food and Drug Administration
  • Consulting And Research Firm

Report Description:

  • Global Histology and cytology Market, Industry Analysis, Trends, Analysis and Forecast, 2021 to 2028 is a forthcoming/imminent research report which is to be published by The Brainy Insights.
  • 2020 is considered as the base year of the report. 2018 and 2019 are considered as the historic years and 2021 to 2028 are the forecast years. The global histology and cytology market is based on revenue (USD Million/Billion). The report incorporates the market study on the basis of revenue. The study covers the market share revenue/market share for each of the segments, regions and countries catering to global histology and cytology market. The regions analyzed for the market are Europe, Asia Pacific, North America, South America and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
  • The report encompasses with the relative data & information, which have been validated by the leading industry professionals and experts all across the globe. The research report also delivers an outline of the attractiveness of histology and cytology and regions which are deduced and formulated on the basis of their growth rate (CAGR), market size, and attractiveness by analyzing the present and future prospects to market growth and development in future.
  • The report illustrates the detailed (both quantitative and qualitative) analysis of historical data, revenues, key developments, along with the crucial strategies adopted by key organizations catering to global histology and cytology market. This offers vital and in depth insights in order to depict the overall market scenario.
  • The report offers the detailed study for the company profiles of key organizations operating in the global histology and cytology market and a comparative assessment based on their product offering, business overviews, geographic presence, business strategies, segment market share, product development & innovations, recent developments, joint venture, partnerships, mergers & acquisitions, strategic alliances, SWOT analysis, and key financial information. This helps in evaluating the overall competition present in the market scenario. 
  • The report provides an elaborative assessment of the porter’s five forces analysis coupled with SWOT analysis so as to provide business related data and information’s. Porter’s five forces model is analyzed to understand the overall competitive scenario that is prevailing in the market. Additionally, the SWOT analysis identifies both the positive and negative attributes of the market development which influences the company growth and development in order to sustain and survive in the long run.
  • Along with that, the report also focuses on the market related driving factors, growth limitations (restraints), potential industry opportunities, significant trends and development which act as a key potential for the investors. 
  • Potential growth prospects along with the penetration rate analysis of the products (market related i.e., global histology and cytology market is covered in order to comprehend the adoption rate and evaluate the market size.

Frequesntly Asked Questions

As per The Brainy Insights, the size of the histology and cytology market was valued at USD 12.32 billion in 2020 and is anticipated to reach USD 33.69 billion by 2028.

Global histology and cytology market is growing at a CAGR of 14.97% during the forecast period 2021-2028.

The global histology and cytology market has been segmented based on type, test type, application, end-user, and regions. The cytology segment held the largest market share in 2020

The North America region emerged as the largest market for the histology and cytology.

Increasing prevalence of cancer across the globe is the key driving factor for the histology and cytology market.

Risk of contamination may hamper the market growth.

Growth opportunities in the emerging economies will provide huge opportunities to the market.

Key players are Abbott Laboratories, Becton Dickinson and Company, Danaher, F. Hoffmann-La Roche Ltd, Hologic, Inc., Sysmex Corporation.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Type
          4.3.2. Market Attractiveness Analysis By Test Type
          4.3.3. Market Attractiveness Analysis By Application
          4.3.4. Market Attractiveness Analysis By End User
          4.3.5. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increasing prevalence of cancer across the globe
          5.2.2. Technological advancement in the diagnostics techniques
    5.3. Restrains
          5.3.1. Risk of contamination
    5.4. Opportunities
          5.4.1. Growth opportunities in the emerging economies
    5.5. Challenges
          5.5.1. Lack of awareness in the emerging countries

6. Global Histology and Cytology Market Analysis and Forecast, By Type
    6.1. Segment Overview
    6.2. Histology
    6.3. Cytology
          6.3.1. Cervical Cancer
          6.3.2. Breast Cancer
          6.3.3. Other Cancers

7. Global Histology and Cytology Market Analysis and Forecast, By Test Type
    7.1. Segment Overview
    7.2. Microscopy Tests
    7.3. Molecular Genetics Tests
          7.3.1. Cytogenic tests
          7.3.2. Polymerase chain reaction
          7.3.3. Others
    7.4. Flow Cytometry

8. Global Histology and Cytology Market Analysis And Forecast, By Application
    8.1. Segment Overview
    8.2. Clinical Diagnostics
    8.3. Molecular Diagnostics Study
    8.4. Cell Signaling
    8.5. Others

9. Global Histology and Cytology Market Analysis and Forecast, By End User
    9.1. Segment Overview
    9.2. Hospitals/Clinics
    9.3. Biopharmaceutical Companies
    9.4. Academia
    9.5. Others

10. Global Histology and Cytology Market Analysis and Forecast, By Regional Analysis
    10.1. Segment Overview
    10.2. North America
          10.2.1. U.S.
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Europe
          10.3.1. Germany
          10.3.2. France
          10.3.3. U.K.
          10.3.4. Italy
          10.3.5. Spain
    10.4. Asia-Pacific
          10.4.1. Japan
          10.4.2. China
          10.4.3. India
    10.5. South America
          10.5.1. Brazil
    10.6. Middle East and Africa
          10.6.1. UAE
          10.6.2. South Africa

11. Global Histology and Cytology Market-Competitive Landscape
    11.1. Overview
    11.2. Market Share of Key Players in Global Histology and Cytology Market
          11.2.1. Global Company Market Share
          11.2.2. North America Company Market Share
          11.2.3. Europe Company Market Share
          11.2.4. APAC Company Market Share
    11.3. Competitive Situations and Trends
          11.3.1. Product Launches and Developments
          11.3.2. Partnerships, Collaborations, and Agreements
          11.3.3. Mergers & Acquisitions
          11.3.4. Expansions

12. Company Profiles
    12.1. Abbott Laboratories
          12.1.1. Business Overview
          12.1.2. Company Snapshot
          12.1.3. Company Market Share Analysis
          12.1.4. Company Product Portfolio
          12.1.5. Recent Developments
          12.1.6. SWOT Analysis
    12.2. Becton Dickinson and Company
          12.2.1. Business Overview
          12.2.2. Company Snapshot
          12.2.3. Company Market Share Analysis
          12.2.4. Company Product Portfolio
          12.2.5. Recent Developments
          12.2.6. SWOT Analysis
    12.3. Danaher
          12.3.1. Business Overview
          12.3.2. Company Snapshot
          12.3.3. Company Market Share Analysis
          12.3.4. Company Product Portfolio
          12.3.5. Recent Developments
          12.3.6. SWOT Analysis
    12.4. F. Hoffmann-La Roche Ltd
          12.4.1. Business Overview
          12.4.2. Company Snapshot
          12.4.3. Company Market Share Analysis
          12.4.4. Company Product Portfolio
          12.4.5. Recent Developments
          12.4.6. SWOT Analysis
    12.5. Hologic, Inc.
          12.5.1. Business Overview
          12.5.2. Company Snapshot
          12.5.3. Company Market Share Analysis
          12.5.4. Company Product Portfolio
          12.5.5. Recent Developments
          12.5.6. SWOT Analysis
    12.6. Sysmex Corporation
          12.6.1. Business Overview
          12.6.2. Company Snapshot
          12.6.3. Company Market Share Analysis
          12.6.4. Company Product Portfolio
          12.6.5. Recent Developments
          12.6.6. SWOT Analysis
    12.7. Thermo Fisher Scientific, Inc.
          12.7.1. Business Overview
          12.7.2. Company Snapshot
          12.7.3. Company Market Share Analysis
          12.7.4. Company Product Portfolio
          12.7.5. Recent Developments
          12.7.6. SWOT Analysis
    12.8. Trivitron Healthcare.
          12.8.1. Business Overview
          12.8.2. Company Snapshot
          12.8.3. Company Market Share Analysis
          12.8.4. Company Product Portfolio
          12.8.5. Recent Developments
          12.8.6. SWOT Analysis
    12.9. Southwest Precision Instruments
          12.9.1. Business Overview
          12.9.2. Company Snapshot
          12.9.3. Company Market Share Analysis
          12.9.4. Company Product Portfolio
          12.9.5. Recent Developments
          12.9.6. SWOT Analysis
    12.10. Merck KGaA
          12.10.1. Business Overview
          12.10.2. Company Snapshot
          12.10.3. Company Market Share Analysis
          12.10.4. Company Product Portfolio
          12.10.5. Recent Developments
          12.10.6. SWOT Analysis
    12.11. Allergan, Plc
          12.11.1. Business Overview
          12.11.2. Company Snapshot
          12.11.3. Company Market Share Analysis
          12.11.4. Company Product Portfolio
          12.11.5. Recent Developments
          12.11.6. SWOT Analysis
    12.12. Promega Corporation
          12.12.1. Business Overview
          12.12.2. Company Snapshot
          12.12.3. Company Market Share Analysis
          12.12.4. Company Product Portfolio
          12.12.5. Recent Developments
          12.12.6. SWOT Analysis
    12.13. Agilent Technologies Inc.
          12.13.1. Business Overview
          12.13.2. Company Snapshot
          12.13.3. Company Market Share Analysis
          12.13.4. Company Product Portfolio
          12.13.5. Recent Developments
          12.13.6. SWOT Analysis

List of Table

1. Global Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

2. Global Histology, Histology and Cytology Market, By Region, 2018–2028 (USD Billion)

3. Global Cytology, Histology and Cytology Market, By Region, 2018–2028 (USD Billion)

4. Global Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

5. Global Microscopy Tests Histology and Cytology Market, By Region, 2018–2028 (USD Billion)

6. Global Molecular Genetics Tests Histology and Cytology Market, By Region, 2018–2028 (USD Billion)

7. Global Flow Cytometry Histology and Cytology Market, By Region, 2018–2028 (USD Billion)

8. Global Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

9. Global Clinical Diagnostics Histology and Cytology Market, By Region, 2018–2028 (USD Billion)

10. Global Molecular Diagnostics Study Histology and Cytology Market, By Region, 2018–2028 (USD Billion)

11. Global Cell Signaling Histology and Cytology Market, By Region, 2018–2028 (USD Billion)

12. Global Others Histology and Cytology Market, By Region, 2018–2028 (USD Billion)

13. Global Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

14. Global Hospitals/Clinics Histology and Cytology Market, By Region, 2018–2028 (USD Billion)

15. Global Biopharmaceutical Companies Histology and Cytology Market, By Region, 2018–2028 (USD Billion)

16. Global Academia Histology and Cytology Market, By Region, 2018–2028 (USD Billion)

17. Global Others Histology and Cytology Market, By Region, 2018–2028 (USD Billion)

18. Global Histology and Cytology Market, By Region, 2018–2028 (USD Billion)

19. Global Histology and Cytology Market, By North America, 2018–2028 (USD Billion)

20. North America Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

21. North America Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

22. North America Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

23. North America Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

24. U.S. Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

25. U.S. Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

26. U.S. Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

27. U.S. Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

28. Canada Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

29. Canada Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

30. Canada Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

31. Canada Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

32. Mexico Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

33. Mexico Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

34. Mexico Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

35. Mexico Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

36. Europe Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

37. Europe Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

38. Europe Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

39. Europe Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

40. Germany Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

41. Germany Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

42. Germany Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

43. Germany Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

44. France Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

45. France Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

46. France Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

47. France Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

48. U.K. Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

49. U.K. Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

50. U.K. Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

51. U.K. Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

52. Italy Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

53. Italy Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

54. Italy Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

55. Italy Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

56. Spain Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

57. Spain Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

58. Spain Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

59. Spain Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

60. Asia Pacific Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

61. Asia Pacific Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

62. Asia Pacific Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

63. Asia Pacific Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

64. Japan Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

65. Japan Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

66. Japan Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

67. Japan Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

68. China Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

69. China Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

70. China Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

71. China Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

72. India Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

73. India Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

74. India Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

75. India Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

76. South America Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

77. South America Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

78. South America Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

79. South America Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

80. Brazil Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

81. Brazil Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

82. Brazil Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

83. Brazil Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

84. Middle East and Africa Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

85. Middle East and Africa Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

86. Middle East and Africa Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

87. Middle East and Africa Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

88. UAE Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

89. UAE Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

90. UAE Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

91. UAE Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

92. South Africa Histology and Cytology Market, By Type, 2018–2028 (USD Billion)

93. South Africa Histology and Cytology Market, By Test Type, 2018–2028 (USD Billion)

94. South Africa Histology and Cytology Market, By Application, 2018–2028 (USD Billion)

95. South Africa Histology and Cytology Market, By End User, 2018–2028 (USD Billion)

List of Figures 

1. Global Histology and Cytology Market Segmentation

2. Histology and Cytology Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Histology and Cytology Market Attractiveness Analysis By Type

9. Global Histology and Cytology Market Attractiveness Analysis By Test Type

10. Global Histology and Cytology Market Attractiveness Analysis By Application

11. Global Histology and Cytology Market Attractiveness Analysis By End User

12. Global Histology and Cytology Market Attractiveness Analysis By Region

13. Global Histology and Cytology Market: Dynamics

14. Global Histology and Cytology Market Share by Type(2021 & 2028)

15. Global Histology and Cytology Market Share By Test Type(2021 & 2028)

16. Global Histology and Cytology Market Share By Application(2021 & 2028)

17. Global Histology and Cytology Market Share By End User(2021 & 2028)

18. Global Histology and Cytology Market Share by Regions (2021 & 2028)

19. Global Histology and Cytology Market Share by Company (2020)

This study forecasts revenue at global, regional, and country levels from 2018 to 2028. The Brainy Insights has segmented the global histology and cytology market on the basis of below mentioned segments:

Global Histology and Cytology Market by Type:

  • Histology
  • Cytology
    • Cervical Cancer
    • Breast Cancer
    • Other Cancers

Global Histology and Cytology Market by Test Type:

  • Microscopy Tests
  • Molecular Genetics Tests
    • Cytogenic tests
    • Polymerase chain reaction
    • Others
  • Flow Cytometry

Global Histology and Cytology Market by Application:

  • Clinical Diagnostics
  • Molecular Diagnostics Study
  • Cell Signaling
  • Others

Global Histology and Cytology Market by End User:

  • Hospitals/Clinics
  • Biopharmaceutical Companies
  • Academia
  • Others

Global Histology and Cytology Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date